Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A

Autor: Paul Saultier, Yves Guillaume, Virginie Demiguel, Claire Berger, Annie Borel-Derlon, Ségolène Claeyssens, Annie Harroche, Caroline Oudot, Anne Rafowicz, Marc Trossaert, Bénédicte Wibaut, Christine Vinciguerra, Mohamed Boucekine, Karine Baumstarck, Sandrine Meunier, Thierry Calvez, Hervé Chambost, Achille Aouba, Faezeh Legrand, Chantal Rothschild, Marie-Françoise Torchet, Roseline d’Oiron, Thierry Lambert, Yves Laurian, Jennifer Biernat, Jenny Goudemand, Armelle Parquet, Véronique Tintillier, Anne Durin Assollant, Claude Négrier, Sabine Castet, Viviane Guérin, Yohann Huguenin, Marguerite Micheau, Anne Ryman, Hérve Chambost, Céline Falaise, Marie Françoise Thiercelin-Legrand, Marianne Fiks-Sigaud, Marc Fouassier, Edith Fressinaud, Sophie Voisin, Albert Faradji, Patrick Lutz, Marie Elisabeth Briquel, Birgit Frotscher, Béatrice Fimbel, Yves Gruel, Claude Guerois, Sandra Regina, Jean Baptiste Valentin, Christine Biron Andreani, Philippe Codine, Daniel Donadio, Robert Navarro, Paola Rospide, Jean-François Schved, Bénédicte Collet, Annie Borel Derlon, Philippe Gautier, Sophie Bayart, Ben⊚ıt Guillet, JeanneYvonne Borg, Cécile Dumesnil, Charline Normand, Pascale Schneider, Philippe Tron, Jean-Pierre Vannier, Fabienne Dutrillaux, Fabienne Volot, Piotr Gembara, Alain Marques-Verdier, Dalila Adjaoud, Claire Barro, Gilles Pernod, Ben⊚ıt Polack, Patricia Pouzol, Nadra Ounnoughene, Patricia Paugy, Valérie Robert, Natalie Stieltjes, Brigitte Bastenaire, Emmanuelle de Raucourt, Jocelyne Peynet, Valérie Li-Thiao-Te, Brigitte Pautard, Catherine Behar, Stéphanie Gorde, Martine Munzer, Valérie Gay, Elisabeth Benz Lemoine, Laurent Macchi, Lionel De Lumley, Solange Gaillard, Anne Deville, Fabrice Monpoux, Marie Anne Bertrand, Brigitte Pan-Petesch, Abel Hassoun, Brigitte Coatmelec, Philippe Beurrier, Michèle Damay, Philippe Moreau, Odile Pouille-Lievin, Caroline Schoepfer, Eliane Tarral, Monique Bianchin, Joël Nguyen, Olivier Pincemaille, Marie-Odile Peter

Publikováno v: The Journal of Pediatrics
The Journal of Pediatrics, 2021, 234, pp.212-219.e3. ⟨10.1016/j.jpeds.2021.02.071⟩

International audience; Objectives: To evaluate the applicability and compliance with guidelines for early initiation of long-term prophylaxis in infants with severe hemophilia A and to identify factors associated with guideline compliance.Study desi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a04ba22efe053930d53178ae033337db
https://doi.org/10.1016/j.jpeds.2021.02.071

Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study

Autor: C. Boyer-Neumann, F. Bauduer, E. de Raucourt, Marc Trossaert, Jocelyne Peynet, F. Bridey, Jenny Goudemand, J.-Y. Borg, Céline Henriet, A. Faradji, Pierre Chamouni, C. Chatelanaz, Philippe Beurrier

Publikováno v: Haemophilia

Summary Factor XI (FXI)-deficient patients may develop excessive bleeding after trauma or surgery. Replacement therapy should be considered in high-risk situations, especially when FXI levels are below 20 IU dL−1. HEMOLEVEN is a human plasma-derive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d9be918d42315ff931f414f2e1ffc86
https://pubmed.ncbi.nlm.nih.gov/25817556

Inherited factor VII deficiency and surgery: clinical data are the best criteria to predict the risk of bleeding

Autor: Muriel Giansily Blaizot, Christine Biron-Andreani, Patricia Aguilar-Martinez, Philippe De Moeloose, Marie-Elisabeth Briquel, Jenny Goudemand, Nathalie Stieltjes, Claire Barrot, Herve Chambost, Anne Durin, Valerie Gay, Jocelyne Peynet, Katia Pouymayou, Jean-François Schved

Publikováno v: British Journal of Haematology. 117:172-175

Inherited factor VII (FVII) deficiency is a rare autosomal disorder characterized by a weak relationship between FVII activity (FVII:C) and operative bleeding risk. We report a retrospective study of 17 patients with a FVII:C below 0.1 IU/ml, in whom

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4ade8f9ed8421d4f146e6aeae0803197
https://doi.org/10.1046/j.1365-2141.2002.03408.x

Detection of 95 novel mutations in coagulation factor VIII gene F8 responsible for hemophilia A: results from a single institution

Autor: Thierry Lambert, Jocelyne Peynet, Roseline d'Oiron, Jean-Marc Costa, Y. Laurian, Benoît Guillet, Jean-Maurice Lavergne, Valérie Proulle, Laurence Bendelac, Anne Rafowicz, Jean-Luc Plantier

Publikováno v: Human mutation. 27(7)

Hemophilia A (HA) is an X-linked hereditary bleeding disorder defined by a qualitative and/or quantitative factor VIII (FVIII) deficiency. The molecular diagnosis of HA is challenging because of the high number of different causative mutations that a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ba7cc1a90faaf5b4f525453f25b1aae
https://pubmed.ncbi.nlm.nih.gov/16786531

Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate

Autor: Yvette Sultan, Jocelyne Peynet, Anne Durin, Valérie Gay, Claude Guérois, Robert Navarro, Chantal Rothschild, Yves Laurian, Armelle Parquet

Publikováno v: Thrombosis and haemostasis. 82(4)

SummaryFifteen previously untreated patients (Pups) with severe haemophilia B (factor IX activity ≤ 2 U/dl) only treated with one brand of plasma-derived high purity factor IX concentrate (FIX LFB) were studied. Age at first injection varied from 1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c49e593cdf24f97a10090303d0c712f
https://pubmed.ncbi.nlm.nih.gov/10544907